๎๊ฒ์
๎๊ฒ์
๎
Arcus Biosciences Inc
RCUS๎ญ๊ด์ฌ ๋ชฉ๋ก์ ์ถ๊ฐ
25.240USD
-0.300-1.17%
์ข
๊ฐย 09-18 16:00๏ผET๏ผ
3.21B์๊ฐ์ด์ก
์์คP/E TTM
์ฅ์ธ ๊ฑฐ๋ย 19:00ย (ET)25.240USD+0.030+0.12%
์ฅ์ธ ๊ฑฐ๋ย 19:00ย (ET)Arcus Biosciences Inc(RCUS) ์์ต ์ฑ๊ณผ
๋ง์ง๋ง ์ ๋ฐ์ดํธ: Jun 30, 2026์๋ , Arcus Biosciences Inc์ ๊ฐ์ฅ ์ข์ ์ฑ๊ณผ๋ฅผ ๋ธ ๋ถ๋ฌธ์ธ License and development services revenue๋ 221.00M๋ฌ๋ฌ์ ์์ต์ ์ฌ๋ ธ์ต๋๋ค. United States์ด ๊ฐ์ฅ ํฐ ๊ธฐ์ฌ๋ฅผ ํ์ฌ, ์๋ ์ 382.88M๋ฌ๋ฌ์ ๋ฌํ์ต๋๋ค.
์ฌ์ ๋ณ
์์ต
๋น์จ
์ฐ๊ฐ๎ฎ
์ฐ๊ฐ
๋ถ๊ธฐ๋ณ
License and development services revenue
Collaboration revenue
License revenue
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
License and development services revenue
221.00M(89.47%)
222.00M(86.05%)
80.00M(68.38%)
74.00M(66.07%)
1.14M(0.30%)
--(--)
Collaboration revenue
26.00M(10.53%)
36.00M(13.95%)
37.00M(31.62%)
38.00M(33.93%)
37.91M(9.90%)
22.42M(28.92%)
License revenue
--(--)
--(--)
--(--)
--(--)
343.84M(89.80%)
55.10M(71.08%)
์ง์ญ๋ณ
์์ต
๋น์จ
์ฐ๊ฐ๎ฎ
์ฐ๊ฐ
๋ถ๊ธฐ๋ณ
United States
FY2021
United States
382.88M(100.00%)